Coronavirus disease 2019 (COVID-19) has not only impacted the health of millions of people globally but has also changed the delivery of medical care and hospital admission patterns across the world [1,2]. In the realm of cardiovascular diseases, the impact of COVID-19 has been felt beyond the direct patient-related consequences, causing disruption of cardiac services and reallocation of their resources [2,3]. Deferred elective services may not be immediately consequential; however, in patients presenting with ST elevation myocardial infarction (STEMI), ischemic time duration is a major determinant of infarct size, and delay can lead to higher morbidity and mortality [4]. This, along with patients' reluctance to seek emergent medical care, could lead to further harm and higher complication rates. In this issue of Cardiovascular Revascularization Medicine, Haddad et al. have attempted to report the magnitude of the effect of COVID-19 on STEMI system performance metrics and its impact on patient-related outcomes from an epicenter of COVID-19 infection in Montreal, Canada.